478 related articles for article (PubMed ID: 31730760)
1. Old wine in new bottles: Drug repurposing in oncology.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Curr Med Chem; 2021; 28(11):2137-2174. PubMed ID: 32895037
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
5. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
K W To K; Cho WCS
Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
[TBL] [Abstract][Full Text] [Related]
6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
7. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
Roy S; Dhaneshwar S; Bhasin B
Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
[TBL] [Abstract][Full Text] [Related]
8. Drug Repurposing in the Development of Anticancer Agents.
Olgen S; Kotra LP
Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug.
Saengboonmee C; Sanlung T; Wongkham S
Anticancer Res; 2021 Dec; 41(12):5913-5918. PubMed ID: 34848445
[TBL] [Abstract][Full Text] [Related]
10. Repurposing medicinal compounds for blood cancer treatment.
McCabe B; Liberante F; Mills KI
Ann Hematol; 2015 Aug; 94(8):1267-76. PubMed ID: 26048243
[TBL] [Abstract][Full Text] [Related]
11. Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments.
Juárez-López D; Schcolnik-Cabrera A
Arch Med Res; 2021 Apr; 52(3):243-251. PubMed ID: 33190955
[TBL] [Abstract][Full Text] [Related]
12. Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs.
Rohilla A; Rohilla S
Curr Drug Discov Technol; 2024; 21(1):e101023222023. PubMed ID: 38629171
[TBL] [Abstract][Full Text] [Related]
13. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead.
Shah RR; Stonier PD
J Clin Pharm Ther; 2019 Feb; 44(1):6-22. PubMed ID: 30218625
[TBL] [Abstract][Full Text] [Related]
14. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment.
Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A
Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997
[TBL] [Abstract][Full Text] [Related]
15. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
[TBL] [Abstract][Full Text] [Related]
16. Developing Novel Anticancer Drugs for Targeted Populations: An Update.
Tafesse TB; Bule MH; Khan F; Abdollahi M; Amini M
Curr Pharm Des; 2021; 27(2):250-262. PubMed ID: 33234093
[TBL] [Abstract][Full Text] [Related]
17. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs.
Bhattarai D; Singh S; Jang Y; Hyeon Han S; Lee K; Choi Y
Curr Top Med Chem; 2016; 16(19):2156-68. PubMed ID: 26881715
[TBL] [Abstract][Full Text] [Related]
18. Drug rechanneling: A novel paradigm for cancer treatment.
Kaushik I; Ramachandran S; Prasad S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
[TBL] [Abstract][Full Text] [Related]
19. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
20. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]